173(top 1%)
PR articles
6.7K(top 2%)
PR citations
51(top 1%)
PR h-index
53(top 1%)
h-index
185
documents
8.1K
doc citations
2.3K
citing journals
100
times ranked

Publications

178 peer-reviewed articles • 7,381 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
European Heart Journal, 2025, 46, 1096-1108
2.245Citations (PDF)
2Association of Albuminuria Within the Normoalbuminuric Range With All‐Cause Mortality in People With Type 2 Diabetes4.80Citations (PDF)
3Validation in type 2 diabetes of a metabolomic signature of all‐cause mortality4.82Citations (PDF)
4Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes0.511Citations (PDF)
5Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study9.416Citations (PDF)
6TIMP3 overexpression in myeloid lineage alleviates pancreatic damage and confers resistance to the development of type 1 diabetes in the MLDS -induced model3.84Citations (PDF)
7Renal Expression and Localization of the Receptor for (Pro)renin and Its Ligands in Rodent Models of Diabetes, Metabolic Syndrome, and Age-Dependent Focal and Segmental Glomerulosclerosis4.43Citations (PDF)
8Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction
Cells, 2024, 13, 763
4.631Citations (PDF)
9Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study
Acta Diabetologica, 2024, 61, 1107-1116
2.23Citations (PDF)
10Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes3.82Citations (PDF)
11Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study2.74Citations (PDF)
12Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
Diabetes and Metabolism, 2023, 49, 101413
3.513Citations (PDF)
13Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes4.821Citations (PDF)
14Sustained increase in physical fitness independently predicts improvements in cardiometabolic risk profile in type 2 diabetes4.87Citations (PDF)
15The “sweet” path to cancer: focus on cellular glucose metabolism2.617Citations (PDF)
16Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report
Tumori, 2023, 109, NP21-NP26
1.41Citations (PDF)
17Relationships of Changes in Physical Activity and Sedentary Behavior With Changes in Physical Fitness and Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes: The Italian Diabetes and Exercise Study 2 (IDES_2)
Diabetes Care, 2022, 45, 213-221
6.234Citations (PDF)
18Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes
Acta Diabetologica, 2022, 59, 747-750
2.21Citations (PDF)
19Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet
Nutrients, 2022, 14, 1061
4.424Citations (PDF)
20Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes
Diabetes and Metabolism, 2022, 48, 101353
3.55Citations (PDF)
21Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT Scan3.810Citations (PDF)
22Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
Acta Diabetologica, 2022, 59, 1369-1381
2.25Citations (PDF)
23Effects of physical activity/exercise on bone metabolism, bone mineral density and fragility fractures
2022, 2, 20-24
4Citations (PDF)
24Sustained decreases in sedentary time and increases in physical activity are associated with preservation of estimated β-cell function in individuals with type 2 diabetes5.83Citations (PDF)
25Mutual Regulation between Redox and Hypoxia-Inducible Factors in Cardiovascular and Renal Complications of Diabetes
Antioxidants, 2022, 11, 2183
5.836Citations (PDF)
26Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study9.413Citations (PDF)
27Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy5.514Citations (PDF)
28Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
BMC Medicine, 2021, 19,
7.1150Citations (PDF)
29The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation2.03Citations (PDF)
30Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future
Antioxidants, 2021, 10, 727
5.8132Citations (PDF)
31Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer3.820Citations (PDF)
32Female Sexual Dysfunction in Primary Adrenal Insufficiency2.56Citations (PDF)
33Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel3.216Citations (PDF)
34Sedentary behaviour is an independent predictor of diabetic foot ulcer development: An 8-year prospective study5.824Citations (PDF)
35Normalizing HIF-1α Signaling Improves Cellular Glucose Metabolism and Blocks the Pathological Pathways of Hyperglycemic Damage
Biomedicines, 2021, 9, 1139
3.430Citations (PDF)
36Effect of a Behavioural Intervention for Adoption and Maintenance of a Physically Active Lifestyle on Psychological Well-Being and Quality of Life in Patients with Type 2 Diabetes: The IDES_2 Randomized Clinical Trial
Sports Medicine, 2021, 52, 643-654
6.217Citations (PDF)
37Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Cancers, 2021, 13, 313
3.859Citations (PDF)
38Muscle fatigability in patients with type 2 diabetes: relation with long‐term complications4.816Citations (PDF)
39Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society3.220Citations (PDF)
40The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders
Cells, 2020, 9, 1812
4.681Citations (PDF)
41Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice11.324Citations (PDF)
42Gestione delle endocrinopatie nel paziente talassemico adulto politrasfuso
L Endocrinologo, 2020, 21, 15-16
0.00Citations (PDF)
43Renal protection with glucagon-like peptide-1 receptor agonists3.832Citations (PDF)
44Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Acta Diabetologica, 2020, 57, 1275-1285
2.258Citations (PDF)
45Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis
Scientific Reports, 2020, 10,
3.419Citations (PDF)
46Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment2.55Citations (PDF)
47L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes
Current Medicinal Chemistry, 2020, 27, 1744-1763
2.936Citations (PDF)
48Sedentariness and Urinary Metabolite Profile in Type 2 Diabetic Patients, a Cross-Sectional Study
Metabolites, 2020, 10, 205
3.47Citations (PDF)
49Invest in METs, Not in Meds2.01Citations (PDF)
50Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”3.2105Citations (PDF)
51Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients
Journal of Hepatology, 2019, 70, 954-962
4.221Citations (PDF)
52Management of diabetes mellitus in patients undergoing liver transplantation
Pharmacological Research, 2019, 141, 556-573
9.131Citations (PDF)
53Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
BMC Medicine, 2019, 17,
7.110Citations (PDF)
54Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes16.5131Citations (PDF)
55Metabolically healthy versus metabolically unhealthy obesity9.1402Citations (PDF)
56Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
Journal of Nephrology, 2019, 33, 9-35
1.5109Citations (PDF)
57Study to Weigh the Effect of Exercise Training on BONE quality and strength (SWEET BONE) in type 2 diabetes: study protocol for a randomised clinical trial
BMJ Open, 2019, 9, e027429
1.98Citations (PDF)
58Haemoglobin A1c variability is a strong, independent predictor of all‐cause mortality in patients with type 2 diabetes4.562Citations (PDF)
59Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice9.137Citations (PDF)
60The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its prevention
Journal of Pathology, 2018, 245, 197-208
4.957Citations (PDF)
61Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
Acta Diabetologica, 2018, 55, 603-612
2.245Citations (PDF)
62Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data10.79Citations (PDF)
63FL‐926‐16, a novel bioavailable carnosinase‐resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice6.343Citations (PDF)
64The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial0.437Citations (PDF)
65Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study
Diabetologia, 2018, 61, 2277-2289
7.5101Citations (PDF)
66Muscle fatigability in type 2 diabetes4.827Citations (PDF)
67The impact of type 1 diabetes and diabetic polyneuropathy on muscle strength and fatigability
Acta Diabetologica, 2017, 54, 543-550
2.248Citations (PDF)
68Extracorporeal Shockwave Therapy Improves Functional Outcomes of Adhesive Capsulitis of the Shoulder in Patients With Diabetes
Diabetes Care, 2017, 40, e12-e13
6.216Citations (PDF)
69Effect of a Behavioral Intervention Strategy for Adoption and Maintenance of a Physically Active Lifestyle: The Italian Diabetes and Exercise Study 2 (IDES_2)
Diabetes Care, 2017, 40, 1444-1452
6.233Citations (PDF)
70Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial21.7272Citations (PDF)
71Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis4.442Citations (PDF)
72Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients1.934Citations (PDF)
73Level and correlates of physical activity and sedentary behavior in patients with type 2 diabetes: A cross-sectional analysis of the Italian Diabetes and Exercise Study_2
PLoS ONE, 2017, 12, e0173337
2.335Citations (PDF)
74Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study
PLoS ONE, 2017, 12, e0185371
2.39Citations (PDF)
75Role of Galectin‐3 in Obesity and Impaired Glucose Homeostasis7.781Citations (PDF)
76Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy2.450Citations (PDF)
77A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies
Annals of Anatomy, 2016, 207, 2-8
1.514Citations (PDF)
78Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics4.074Citations (PDF)
79Neuromuscular dysfunction in type 2 diabetes: underlying mechanisms and effect of resistance training4.871Citations (PDF)
80Determination of metabolic equivalents during low- and high-intensity resistance exercise in healthy young subjects and patients with type 2 diabetes
Biology of Sport, 2016, 33, 77-82
3.515Citations (PDF)
81Effect Of Motor Nerve Impairment On Muscle Endurance In Type 2 Diabetes Patients0.80Citations (PDF)
82Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES)5.836Citations (PDF)
83Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study
Acta Diabetologica, 2015, 52, 971-981
2.29Citations (PDF)
84Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease
Journal of Hepatology, 2015, 63, 1484-1490
4.275Citations (PDF)
85The dark and bright side of atherosclerotic calcification
Atherosclerosis, 2015, 238, 220-230
1.5174Citations (PDF)
86Galectin-3: an emerging all-out player in metabolic disorders and their complications
Glycobiology, 2015, 25, 136-150
2.2123Citations (PDF)
87Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
PLoS ONE, 2015, 10, e0125512
2.336Citations (PDF)
88Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy2.80Citations (PDF)
89Galectin-3 in diabetic patients2.368Citations (PDF)
90Resistant hypertension in patients with type 2 diabetes
Journal of Hypertension, 2014, 32, 2401-2410
2.140Citations (PDF)
91Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study9.428Citations (PDF)
92Effect of supervised exercise training on musculoskeletal symptoms and function in patients with type 2 diabetes: the Italian Diabetes Exercise Study (IDES)
Acta Diabetologica, 2014, 51, 647-654
2.212Citations (PDF)
93Physical exercise as therapy for type 2 diabetes mellitus4.8196Citations (PDF)
94Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study3.258Citations (PDF)
95Updating the natural history of diabetic nephropathy
Acta Diabetologica, 2014, 51, 905-915
2.2131Citations (PDF)
96Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner
Acta Diabetologica, 2014, 51, 675-678
2.211Citations (PDF)
97Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice
Atherosclerosis, 2014, 235, 438-443
1.552Citations (PDF)
98Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice
Diabetologia, 2014, 58, 845-853
7.564Citations (PDF)
99The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis
Cardiovascular Research, 2013, 100, 472-480
5.5125Citations (PDF)
100Metabolic syndrome after liver transplantation: Short-term prevalence and pre- and post-operative risk factors
Digestive and Liver Disease, 2013, 45, 833-839
2.546Citations (PDF)
101HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes
Diabetes Care, 2013, 36, 2301-2310
6.2147Citations (PDF)
102Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study
Journal of Internal Medicine, 2013, 274, 176-191
7.3126Citations (PDF)
103Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study9.466Citations (PDF)
104Diabetes and bone fragility: a dangerous liaison2.75Citations (PDF)
105The purinergic 2X7 receptor participates in renal inflammation and injury induced by high‐fat diet: possible role of NLRP3 inflammasome activation
Journal of Pathology, 2013, 231, 342-353
4.9109Citations (PDF)
106Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
EMBO Molecular Medicine, 2013, 5, 441-455
7.193Citations (PDF)
107Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study2.969Citations (PDF)
108Neuromuscular Dysfunction in Diabetes0.846Citations (PDF)
109Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice6.072Citations (PDF)
110Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes
Diabetes Care, 2012, 35, 143-149
6.2124Citations (PDF)
111Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes
Diabetes Care, 2012, 35, 2317-2323
6.2119Citations (PDF)
112TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
Diabetes, 2012, 61, 454-462
4.276Citations (PDF)
113Changes in Physical Fitness Predict Improvements in Modifiable Cardiovascular Risk Factors Independently of Body Weight Loss in Subjects With Type 2 Diabetes Participating in the Italian Diabetes and Exercise Study (IDES)
Diabetes Care, 2012, 35, 1347-1354
6.290Citations (PDF)
114D‐carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation
British Journal of Pharmacology, 2012, 166, 1344-1356
6.382Citations (PDF)
115High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study5.829Citations (PDF)
116Effect of High- versus Low-Intensity Supervised Aerobic and Resistance Training on Modifiable Cardiovascular Risk Factors in Type 2 Diabetes; The Italian Diabetes and Exercise Study (IDES)
PLoS ONE, 2012, 7, e49297
2.3106Citations (PDF)
117Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)
Diabetologia, 2012, 55, 579-588
7.574Citations (PDF)
118Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Journal of Hepatology, 2011, 54, 975-983
4.2146Citations (PDF)
119The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes
Atherosclerosis, 2011, 218, 194-199
1.567Citations (PDF)
120Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
Journal of Hypertension, 2011, 29, 1802-1809
2.1229Citations (PDF)
121Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study0.871Citations (PDF)
122Improvement of Quality of Life With Supervised Exercise Training in Subjects With Type 2 Diabetes Mellitus8.128Citations (PDF)
123Increased Tumor Necrosis Factor α–Converting Enzyme Activity Induces Insulin Resistance and Hepatosteatosis in Mice
Hepatology, 2010, 51, 103-110
10.184Citations (PDF)
124Effect of an Intensive Exercise Intervention Strategy on Modifiable Cardiovascular Risk Factors in Subjects With Type 2 Diabetes Mellitus<subtitle>A Randomized Controlled Trial: The Italian Diabetes and Exercise Study (IDES)</subtitle><alt-title>Intensive Exercise and Modifiable CV Risk Factors</alt-title>8.1307Citations (PDF)
125Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice6.090Citations (PDF)
126Self glucose monitoring and physical exercise in diabetes4.87Citations (PDF)
127Physical activity/exercise training in type 2 diabetes. The role of the Italian Diabetes and Exercise Study4.817Citations (PDF)
128Advanced lipoxidation end‐products mediate lipid‐induced glomerular injury: role of receptor‐mediated mechanisms
Journal of Pathology, 2009, 218, 360-369
4.970Citations (PDF)
129Similar energy expenditure from resistance training at moderate and vigorous intensity in subjects with type 2 diabetes5.86Citations (PDF)
130Tissue Inhibitor of Metalloproteinase 3 Deficiency Causes Hepatic Steatosis and Adipose Tissue Inflammation in Mice
Gastroenterology, 2009, 136, 663-672.e4
0.9117Citations (PDF)
131Exercise for the management of type 2 diabetes: a review of the evidence
Acta Diabetologica, 2009, 47, 15-22
2.2231Citations (PDF)
132The Italian Diabetes and Exercise Study (IDES): Design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome3.252Citations (PDF)
133Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X43.332Citations (PDF)
134Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis: Response to Snowling and Hopkins
Diabetes Care, 2007, 30, e25-e25
6.219Citations (PDF)
135Glomerular barrier dysfunction in glomerulosclerosis‐ resistant Milan rats with experimental diabetes: the role of renal haemodynamics
Journal of Pathology, 2007, 213, 210-218
4.914Citations (PDF)
136Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation
Diabetologia, 2007, 50, 1997-2007
7.564Citations (PDF)
137Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease
Diabetologia, 2007, 50, 2591-2599
7.584Citations (PDF)
138High-sensitivity C-reactive protein and Physical Activity in Type 2 Diabetes (T2DM) subjects with Metabolic Syndrome (MTs)0.80Citations (PDF)
139Role of TGF-β/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model0.814Citations (PDF)
140Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases
Kidney International, 2005, 67, 875-885
5.368Citations (PDF)
141Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: Possible permissive role of hemodynamics
Kidney International, 2005, 67, 1440-1452
5.317Citations (PDF)
142Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice3.349Citations (PDF)
143Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptor
FASEB Journal, 2004, 18, 1773-1775
0.6101Citations (PDF)
144Glomerular number and size in Milan hypertensive and normotensive rats
Journal of Hypertension, 2004, 22, 2185-2192
2.121Citations (PDF)
145Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C3.785Citations (PDF)
146Pathogenetic mechanisms of diabetic microangiopathy
International Congress Series, 2003, 1253, 171-182
0.22Citations (PDF)
147Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation4.827Citations (PDF)
14815 th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes
Diabetologia, 2001, 44, 674-692
7.564Citations (PDF)
149Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
FASEB Journal, 2001, 15, 2471-2479
0.6179Citations (PDF)
150The circulating insulin-like growth factor system in children with coeliac disease: an additional marker for disease activity4.819Citations (PDF)
151Eicosanoid synthesis in peripheral blood monocytes: A marker of disease activity in lupus nephritis1.411Citations (PDF)
152Early, but Not Advanced, Glomerulopathy Is Reversed by Pancreatic Islet Transplants in Experimental Diabetic Rats: Correlation With Glomerular Extracellular Matrix mRNA Levels
Diabetes, 1997, 46, 1198-1206
4.233Citations (PDF)
153High glucose level inhibits capacitative Ca 2 + influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism
Diabetologia, 1997, 40, 521-527
7.547Citations (PDF)
154Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production
Diabetologia, 1996, 39, 775-784
7.565Citations (PDF)
155Regulatory role of eicosanoids in extracellular matrix overproduction induced by long-term exposure to high glucose in cultured rat mesangial cells
Diabetologia, 1996, 39, 1055-1062
7.517Citations (PDF)
156Role of advanced glycation end-products (AGE) in late diabetic complications5.857Citations (PDF)
157Mechanisms of Glucose-Enhanced Extracellular Matrix Accumulation in Rat Glomerular Mesangial Cells
Diabetes, 1994, 43, 478-490
4.2130Citations (PDF)
158Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats9.12Citations (PDF)
159High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells
Kidney International, 1993, 43, 585-591
5.361Citations (PDF)
160Selective decrement of anionic immunoglobulin clearance after induced renal hemodynamic changes in diabetic patients3.32Citations (PDF)
161Mechanisms of glucose-induced extracellular matrix overproduction by cultured vascular cells
Acta Diabetologica, 1992, 29, 264-267
2.20Citations (PDF)
162Rapid measurement of glomerular filtration rate in small animals
Kidney International, 1992, 41, 435-439
5.32Citations (PDF)
163Interactions between hypertension and diabetes on vascular function and structure in rats2.48Citations (PDF)
164Discordant effects of the aldose resuctase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats0.123Citations (PDF)
165Glucose‐induced metabolic imbalances in the pathogenesis of diabetic vascular disease2.4138Citations (PDF)
166Effects of Islet Isografts on Hemodynamic and Vascular Filtration Changes in Diabetic Rats
Diabetes, 1990, 39, 323-332
4.225Citations (PDF)
167Modulation of Hemodynamic and Vascular Filtration Changes in Diabetic Rats by Dietary myo-inositol
Diabetes, 1990, 39, 312-322
4.260Citations (PDF)
168Vascular filtration function in galactose-fed versus diabetic rats: The role of polyol pathway activity9.147Citations (PDF)
169Prevention of Hemodynamic and Vascular Albumin Filtration Changes in Diabetic Rats by Aldose Reductase Inhibitors
Diabetes, 1989, 38, 1258-1270
4.2157Citations (PDF)
170Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats
Diabetologia, 1989, 32, 845-857
7.563Citations (PDF)
171Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats9.124Citations (PDF)
172Effects of nephrectomy and high-protein diets on glomerular hemodynamics and urinary protein excretion in diabetic rats0.16Citations (PDF)
173Diabetic complications: Is there a way out of the Labyrinth?0.13Citations (PDF)
174Cortisol Deficiency in Lenvatinib Treatment of Thyroid Cancer: An Underestimated Common Adverse Event
Thyroid, 0, ,
4.410Citations (PDF)
175Protective Role of p66Shc Deletion in Physiological Renal Aging: Effects on G Protein-Coupled Receptor 124 Expression and Associated Cellular Senescence4.40Citations (PDF)
176Effects of Lenvatinib treatment for advanced differentiated thyroid cancer on cortisol deficiency3.81Citations (PDF)
177Growth differentiation factor 15 and the risk of hip fracture in older adults
JBMR Plus, 0, 10,
2.01Citations (PDF)
178Core Needle Biopsy (CNB) and Immunohistochemical Markers in Indeterminate Thyroid Nodules: Evidence and Perspectives2.00Citations (PDF)